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ABSTRACT
Objective: Pathways are succinct, operational versions of evidence-based guidelines. Studies
have demonstrated pathways improve quality of care for children hospitalized with asthma,
but we have limited information on other key factors to guide hospital leaders and clini-
cians in pathway implementation efforts. Our objective was to evaluate the adoption, imple-
mentation, and reach of inpatient pediatric asthma pathways.
Methods: This was a mixed-methods study of hospitals participating in a national collabora-
tive to implement pathways. Data sources included electronic surveys of implementation
leaders and staff, field observations, and chart review of children ages 2-17 years admitted
with a primary diagnosis of asthma. Outcomes included adoption by hospitals, pathway
implementation factors, and reach of pathways to children hospitalized with asthma.
Quantitative data were analyzed using descriptive statistics and multivariable regression.
Qualitative data were analyzed using thematic content analysis.
Results: Eighty-five hospitals enrolled; 68 (80%) adopted/completed the collaborative. These
68 hospitals implemented pathways with overall high fidelity, implementing a median of 5
of 5 core pathway components (Interquartile Range [IQR] 4-5) in a median of 5months (IQR
3-9). Implementation teams reported a median time cost of 78 h (IQR: 40-120) for implemen-
tation. Implementation leaders reported the values of pathway implementation included
improvements in care, enhanced interdisciplinary collaboration, and access to educational
resources. Leaders reported barriers in modifying electronic health records (EHRs), and only
63% of children had electronic pathway orders placed.
Conclusions: Hospitals implemented pathways with high fidelity. Barriers in modifying EHRs
may have limited the reach of pathways to children hospitalized with asthma.
Abbreviations: AAP: American Academy of Pediatrics; QI: quality improvement; EHR: elec-
tronic health record
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Introduction
Asthma affects nearly 10% of American children.
Although asthma-related hospitalizations are largely pre-
ventable, asthma remains a leading cause of childhood
hospitalization (1,2). Pathways are succinct versions of
guidelines that visually guide healthcare providers step-
by-step through the evidence-based care of children
with a specific medical condition. Pathways promote
standardization of care, with the aim of improving care
quality and decreasing unnecessary healthcare utilization.
They have been shown to improve care for children
hospitalized with asthma, including increasing use of
recommended medications, and decreasing length of
hospital stay, healthcare costs, hospital readmissions,
and healthcare disparities (3–9).
Most prior studies of pathways have focused on
determining clinical effectiveness (3,5,7,9). While such
studies are important, they provide limited guidance
on the implementation process for those considering
or leading pathway implementation. A study by
Kaiser et. al. detailed potential barriers and best prac-
tices in asthma pathway implementation (10), and a
study by Pound et. al. described clinicians’ satisfaction
with asthma pathway implementation (11). However,
both of these studies were limited to children’s hospi-
tals. Therefore, prior studies of pathways leave critical
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gaps in our understanding of pathways, such as the
feasibility, fidelity, and time costs of pathway imple-
mentation across diverse hospital settings.
In 2018, the American Academy of Pediatrics
(AAP) Value in Inpatient Pediatrics network launched
a national learning collaborative to implement pediat-
ric inpatient asthma pathways. Pathway implementa-
tion was associated with significant improvements in
quality of care, including increases in early use of
metered-dose inhalers (MDI) and referral of caregivers
to smoking cessation resources. In addition, placement
of pathway orders in the electronic health record was
associated with an 8% reduction in length of hospital
stay (LOS) (12). The purpose of this study was to
evaluate the adoption, implementation, and reach of
pediatric inpatient asthma pathways across the diverse
group of hospitals from around the United States that
participated in this collaborative.
Methods
Study design, setting, and population
This was a mixed-methods study of hospitals participat-
ing in a national learning collaborative– Pathways for
Improving Pediatric Asthma Care (PIPA) (12). PIPA
was led by the AAP’s Value in Inpatient Pediatrics
(VIP) Network, the inpatient pediatric quality improve-
ment (QI) network at the AAP (13). Recruitment
occurred via the VIP electronic mailing list (listserv).
The listserv includes clinicians from 250 hospitals
around the country that range widely in size, type (e.g.
children’s, community), ownership model (e.g. private,
nonprofit), and location (e.g. rural, urban). Hospitals
that joined the collaborative were structurally and geo-
graphically varied, and the populations of children they
serve mirror the diversity of the general U.S. population.
To participate in this collaborative, each institution paid
$750 (to cover administrative costs). The study took
place from January 2018-March 2019 and was approved
by the AAP institutional review board.
Intervention development
A panel of experts assembled by the AAP met regu-
larly throughout 2017 to determine project aims and
select intervention components that supported these
aims (Figure 1). Members of this this panel worked in
diverse hospital settings and had expertise in pediatric
hospital medicine, pediatric emergency medicine,
asthma, quality measurement, quality improvement,
and health services research. Additionally, 2 nurses
and 1 respiratory therapist reviewed and provided
feedback on the intervention.
Intervention description
Participating hospitals were provided a pediatric
asthma pathway implementation toolkit (14), which
included sample evidence-based pathways and sample
order sets based on pathway content. The five core
pathway components included guidance on selection
and dosing of medications (e.g. MDI), standardized
instructions for titrating bronchodilator therapy based
on asthma severity, reminders to screen for secondhand
Figure 1. Blue boxes describe specific aims, orange boxes describe core pathway components, and arrows show the relationship
between these components and the specific aims.
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tobacco smoke exposure, reminders to refer caretakers
to resources for smoking cessation, and hospital dis-
charge criteria. Each hospital designated a local phys-
ician implementation leader, all of whom were
pediatric hospitalists. These leaders recruited local
multidisciplinary teams, including nurses, respiratory
therapists, pharmacists, and administrators. Local teams
adapted and implemented the pathways to fit local
needs and context (e.g. deciding whether nurses or
respiratory therapists would oversee bronchodilator
titration, determining where to integrate reminders to
screen for secondhand tobacco, refining bronchodilator
protocol dosing guidance and discharge criteria based
on local consensus). Implementation involved educat-
ing local clinicians on these core pathway components
and integrating these core pathway components into
clinical workflows (either via paper visual aids or inte-
gration into the electronic health record [EHR]). To
support pathway implementation, we used a learning
collaborative model (15), and each hospital’s physician
implementation leader was provided a physician men-
tor to guide them in the learning collaborative.
Mentors were selected based on experience in pediatric
hospital medicine, QI, and community hospitals. These
mentors met with local implementation leaders
monthly via teleconference for 2months before and
4months after pathway implementation began to pro-
vide support in engaging hospital leadership, garnering
local healthcare provider buy-in, planning improvement
cycles (15), and addressing institutional barriers.
Hospitals were provided several additional resources
for implementation support, including educational
videoconference sessions, educational materials, QI
training, monthly videoconferences for all local imple-
mentation leaders to facilitate peer learning, in-person
meetings at national conferences, monthly audit and
feedback (on local and national performance), and a
free mobile application with pathway content.
Educational videoconference session topics included:
evidence-based asthma care, quality improvement
methodology, leadership, and sustaining quality
improvements. Educational materials included evi-
dence-based pathways and supporting literature.
Theoretical framework
We applied the RE-AIM implementation science
framework (16) to gain a broad understanding of the
impact of the intervention across five domains: reach,
effectiveness, adoption, implementation, and mainten-
ance. For this study, we evaluated adoption, imple-
mentation, and reach. Effectiveness was evaluated
separately and maintenance is currently being eval-
uated. Table 1 outlines the components of the RE-
AIM framework we evaluated, data collection, and
outcomes. Adoption refers to willingness of clinicians
to implement an intervention. Implementation refers
to the fidelity, or consistency, with which the inter-
vention is delivered and the associated costs of deliv-
ering the intervention. Reach assesses the extent to
which the target population of patients who should
have received the intervention actually received it.
Outcomes
Adoption
We evaluated 2 outcomes: 1) participation in the
learning collaborative and associated outcome moni-
toring for the full 15-month study duration, and 2)
perceived barriers to fully participating/adopting (eli-
cited with the question: “Please describe what factors
that led your hospital withdrawing from participating
in the project.”). Our hypothesis was that hospitals
that participated fully/adopted would not significantly
differ from those who dropped out.
Implementation
We evaluated 5 outcomes: 1) fidelity (the number of
core pathway components implemented), 2) time costs
(total number of hours spent on implementation by
local implementation teams), 3) implementation strat-
egies utilized, 4) perceived value of time spent on
Table 1. RE-AIM Domains, data collection, and outcomes.
RE-AIM Domain Description Data Collection Outcomes
Adoption Willingness of clinicians to
implement an intervention
Physician implementation leader
and staff surveys
 Participation in the collaborative and associated data
monitoring for the full study duration
 Perceived barriers to adoption
Implementation Consistency with which an
intervention is delivered (fidelity)
and the associated costs of
delivering the intervention
Physician implementation leader
surveys and field observations
 Fidelity – Number of core components implemented
 Time costs – Total number of hours spent on
implementation by implementation teams
 Implementation strategies utilized
 Perceived value of time spent on pathway
implementation
 Perceived barriers to pathway implementation
Reach Extent to which the intervention
reached the target population
Chart review  Placement of an electronic pathway/protocol order for
standardized bronchodilator titration
JOURNAL OF ASTHMA 3
implementation, and 5) perceived barriers to pathway
implementation. Our hypothesis was that participating
hospitals would achieve high fidelity implementation.
Reach
Developing electronic orders for standardized titration
of bronchodilators has been described as a key elem-
ent of pathway implementation (10,17). We evaluated
1 outcome for “Reach,” placement of an electronic
order in a patient’s chart to use a pathway/protocol
for standardized bronchodilator titration. This out-
come was selected because it is a direct measure of
pathway utilization at the patient level. Our hypothesis
was that the majority of children would be reached by
the pathway intervention.
Data collection
Data collection occurred in three forms: 1) electronic
surveys at all participating hospitals, 2) chart review
of children admitted with asthma at all participating
hospitals, and 3) field observations of 4 participating
hospitals. All survey instruments were beta-tested by a
group of 10 pediatric hospitalist physicians. Each hos-
pital’s physician implementation leader was surveyed
at the beginning of the study to collect information
on hospital characteristics. These responses were veri-
fied using data from the American Hospital
Association Annual Survey Database (18). Data on
organizational readiness to change were collected via
electronic surveys of staff members at each hospital
who were involved in the care of children with asthma
(e.g.physicians, nurses, respiratory therapists; range of
2-20 survey responses per hospital). These surveys
were designed based on the organizational readiness
to change assessment tool (19) and summary scores
were calculated for each hospital (range 1-5). Surveys on
the implementation process (Supplementary Appendix)
were distributed to physician implementation leaders
monthly throughout the pathway implementation period
(January 2018-March 2019) and at the end of the imple-
mentation period (final survey in March 2019). Any dis-
crepancies in survey responses on the implementation
process were resolved via direct contact with physician
implementation leaders at the end of the study.
Data collection also involved chart review of chil-
dren 2–17 years old hospitalized with a primary diag-
nosis of asthma. Chart review was performed at each
site by local physicians or nurses. Reviewers were pro-
vided chart review manuals and trained via videocon-
ference by the central research team. Charts from
January 2018-March 2019 were reviewed prospectively
(during and after pathway implementation). Charts
were selected in chronologic order each month (all
admissions up to a max of 20 per month per hos-
pital). Charts were excluded if children had chronic
medical conditions that precluded pathway use. These
included chronic lung disease (e.g. cystic fibrosis,
restrictive lung disease, bronchopulmonary dysplasia),
congenital or acquired heart disease, airway issues
(e.g.vocal cord paralysis, tracheomalacia, tracheostomy
dependence), immune disorders, sickle cell anemia, or
neuromuscular disorders.
A field observation guide was developed and
reviewed by our study group. In April 2019, one author
(N.G.) conducted the field observations at 4 study sites
within geographic proximity to the central research
team (3 community hospitals and 1 free-standing child-
ren’s hospital). During field observations, self-reported
survey data from physician implementation leaders was
verified and additional qualitative data on barriers to
implementation was collected.
Both chart review and survey administration were
done through REDCap 8.5 (Nashville, TN). Data qual-
ity was audited monthly by the central research team
and by quality audit functions within REDCap.
Analyses
Adoption
We compared characteristics of those hospitals that
“adopted” (defined as participating in the learning col-
laborative and associated outcome monitoring for the
full study duration) to those hospitals that dropped
out of the collaborative using descriptive statistics and
univariate tests (Chi-square test for categorical varia-
bles, Student’s t-test or Mann-Whitney U test for
interval variables). Free-text data on barriers to adop-
tion were summarized by frequency of occurrence.
Implementation
Data on fidelity, time costs, and implementation strat-
egies (e.g. educational videoconferences, improvement
cycles, staff training) were summarized using descriptive
statistics. A staff training score was calculated for each
hospital based on the proportion of clinicians (e.g.
physicians, nurses, respiratory therapists) trained in the
use of each of the 5 core pathway components (for each
component: 0 points if no providers trained, 1 point if
some providers trained, 2 points if all providers trained;
max score of 10 for 5 core components). We compared
implementation data by hospital type (children’s versus
community hospitals) using univariate tests (Chi-square
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test for categorical variables, Student’s t-test or Mann-
Whitney U test for interval variables).
Qualitative data on perceived value of implementa-
tion and barriers to implementation were collected via
2 free-text questions (multiple responses allowed):
“Did you find the PIPA project a valuable use of your
and hospital staff’s time? Please explain why or give
an example of how the project was valuable/
not valuable.”
“Why was this PIPA core intervention not
implemented?”
These qualitative data and notes from field observa-
tions were analyzed using thematic content analysis.
Two authors (N.G. and S.K.) independently coded the
data and developed a preliminary codebook. These two
authors then developed consensus on the codebook and
descriptions of common themes. Differences were
resolved through iterative discussions informed by
review of the collected data and development of consen-
sus across all authors.
Reach
We determined the proportion of children that had
electronic pathway orders placed. This analysis only
included: 1) hospitals that completed the collaborative,
and 2) admissions that occurred during/after pathway
implementation (January 2018 to March 2019). We
used a multi-level logistic regression model (levels:
patient, hospital) to analyze patient characteristics
associated with an increased likelihood of a pathway
order being placed. These characteristics included age,
sex, prior prescription of an inhaled corticosteroid
(proxy for chronic asthma severity), and insurance
type (proxy for socioeconomic status).
All quantitative analyses were performed with SAS
9.4 (Cary, NC), and p values less than 0.05 were consid-
ered statistically significant. All qualitative analyses were
performed with Atlas.ti version 7 (Berlin, Germany).
Results
Adoption
Physicians from a total of 250 hospitals were contacted
via email and 85 hospitals (34%) enrolled in the learn-
ing collaborative. Hospitals that joined were diverse in
terms of size, type, and location (Table 2). Most (92%)
were teaching hospitals. Of the 85 hospitals that joined,
68 (80%) participated in the learning collaborative and
associated outcome monitoring for the full study dur-
ation. Table 2 describes the characteristics of hospitals
that completed the collaborative versus hospitals that
dropped out. No hospital characteristics were statistically
significantly associated with dropping out.
We contacted physician implementation leaders
(pediatric hospitalists) from the 17 hospitals that
dropped out, and 9 (53%) provided responses describ-
ing the reasons for drop out. Reasons included (in
order of frequency): lack of support from hospital
leadership/administrators (n¼ 3), difficulty obtaining
local institutional review board (IRB) approval (n¼ 2),
difficulty obtaining chart review data (n¼ 1), staff
turnover (n¼ 1), difficulty due to competing QI proj-
ects (n¼ 1), and very low patient volumes (n¼ 1).
Implementation
Physician implementation leaders from the 68 hospitals
that completed the collaborative were surveyed regard-
ing implementation, and all responded (Table 3).
Fidelity
Hospitals were able to successfully implement the 5
core components of the pathway intervention (median
5 components, Interquartile Range [IQR] 4–5 compo-
nents). It took a median of 5months to complete
pathway implementation (IQR 3–9months). A total of
39 hospitals (57%) were able to integrate pathways
into the EHR. These outcomes did not vary signifi-
cantly by hospital type.
During field observations at 4 participating hospi-
tals, we verified physician implementation leaders’
survey responses regarding implementation of core
intervention components. All 4 hospitals visited had
self-reported implementation of all 5 core pathway
components, and only 1 component at 1 hospital site
was not visually verified (total 19 of 20 survey
responses/core pathway components verified).
Time costs
The median total time spent on implementation by
local implementation teams over the 15-month collab-
orative was 78 h (IQR 40–120 h). This did not vary
significantly by hospital type.
All respondents (68/68, 100%) also provided free-
text survey responses on perceived value of and bar-
riers to implementation. Descriptions of the most
common themes with exemplary quotes are presented
below in order of frequency of occurrence.
Perceived Value of Implementation
Theme 1: Implementation leaders frequently reported
that they valued the improvements in quality of care
for children that they experienced with pathway
implementation. Implementation leaders reported
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improvements in outcomes for children with asthma
(e.g., decreases in length of hospital stay) as well as
spillover effects to children with other conditions,
such as bronchiolitis.
“The PIPA project allowed us to enact an asthma
pathway, which allows our RTs [respiratory
therapists] and nurses more autonomy, makes our
asthma care more efficient, and hopefully decreases
length of stay. Probably, the biggest change I saw was
a sharp increase in MDI [metered dose inhaler] use
as compared to nebulizer use.” (Site 82)
“The inpatient PIPA project was a valuable us[e] of
our hospital’s time. We were able to transition to
MDIs effectively. We also improved our screening for
tobacco exposure and our counseling for the
patients.” (Site 18)
Table 3. Differences in pathway implementation by hospital type.
All hospitals (n¼ 68)
Children’s Hospital
(n¼ 34)
Community Hospital
(n¼ 34) p-value
Core Interventions Implemented [max: 5] (median, IQR) 5 (4,5) 5 (4,5) 5 (4.5,5) 0.49
Months Taken to Complete Implementation (median, IQR) 5 (3,9) 5 (4,10) 4 (3,8) 0.15
Total Hours Local Leaders Spent on Implementation
(median, IQR) (median, IQR)
78 (40, 120) 98 (55,135) 55 (30,110) 0.26
Electronic Health Record Integration (n, %) 39 (57%) 22 (65%) 17 (50%) 0.22
Educational Webinars Attended [max: 7] (median, IQR) 5 (4,7) 5 (4,6) 5.5 (4,7) 0.95
Staff Training [max: 10] (median, IQR) 7 (4,10) 5 (4,8) 9 (5,10) 0.20
Improvement Cycles Completed (median, IQR) 3 (2,5) 4 (2,5) 3 (2,4) 0.23
The 68 hospitals that completed the collaborative were included in the analyses of implementation.Staff training score calculated based on the proportion of clinicians (e.g., physicians, RTs, nursing, and other support staff) trained in core interventions
Table 2. Characteristics of Hospitals that Completed versus Dropped Out of the PIPA Collaborative.
All hospitals
(n¼ 85)
Hospitals that Completed
PIPA Collaborative
(n¼ 68)
Hospitals that Dropped Out
(n¼ 17) p-value
Hospital Type (n, %)
Children’s Hospital 40 (47.1%) 34 (50%) 6 (35.3%) 0.28
Community Hospital 45 (52.9%) 34 (50%) 11 (64.7%)
Teaching Hospital (n, %) 78 (91.8%) 62 (91.2%) 16 (94.1%) 0.69
Inpatient Pediatric Beds
(mean, SD)
39.3 (50.9) 42.1 (55.2) 28.4(26.6) 0.32
Hospital size (n, %) 0.42
Small (<100) 6 (7.1%) 6 (8.8%) 0 (0.0%)
Medium (100-249) 25 (29.4%) 19 (27.9%) 6 (35.3%)
Large (250) 53 (62.4%) 42 (61.8%) 11 (64.7%)
Geographic Region (n, %) 0.77
West 18 (21.2%) 15 (22.1%) 3 (17.6%)
South 26 (30.6%) 19 (27.9%) 7 (41.2%)
Northeast 14 (16.5%) 11 (16.2%) 3 (17.6%)
Midwest 27 (31.8%) 23 (33.8%) 4 (23.5%)
Location (n, %) 0.08
Urban 39 (45.9%) 32 (47.1%) 7 (41.2%)
Suburban 38 (44.7%) 32 (47.1%) 6 (35.3%)
Rural 8 (9.4%) 4 (5.9%) 4 (23.5%)
Presence of PICU (n, %) 52 (61.2%) 44 (64.7%) 8 (47.1%) 0.18
Ownership Model (n, %) 0.09
Government 9 (10.6%) 6 (8.8%) 3 (17.6%)
Private, nonprofit 68 (80%) 57 (83.8%) 11 (64.7%)
Private, investor owned 6 (7.1%) 3 (4.4%) 3 (17.6%)
Inclusion in Hospital
Network (n, %)
65 (76.5%) 53 (77.9%) 12 (70.6%) 0.45
Presence of Electronic
Health Record (n, %)
83 (97.6%) 66 (97.1%) 17 (100%) 0.47
Total Physicians on Staff for
Inpatient Pediatric Unit
(mean, SD)
7.61 (6.4) 7.96 (6.9) 6.23 (3.4) 0.32
Leadership Support
Obtained Prior to
Initiation (n, %)
78 (91.8%) 63 (92.6%) 15 (88.2%) 0.88
Prior Participation in a
National Learning
Collaborative (n, %)
57 (67.1%) 47 (92.6%) 10 (58.8%) 0.73
Organizational Readiness to
Change Score (mean, SD)
4.09 (0.2) 4.08 (0.2) 4.18 (0.2) 0.22
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Theme 2: Access to educational videoconferences
and materials was often reported as a valuable part of
implementation and the collaborative.
“Yes (it was valuable). Having an organized project
with supporting evidence and education allowed for
much more efficient implementation and getting
providers and nursing staff buy-in in a timely
manner.” (Site 20)
“AAP provided valuable education through
educational videoconferences on quality improvement
tools, design and utilization of Plan Do Study Act
cycles… and strategies to overcome challenges and
promote sustainability.” (Site 69)
Theme 3: Implementation leaders also described
how they valued the cultivation of interdisciplinary
collaboration. They described increased collaboration
among physicians across varying specialties, nurses,
respiratory therapists, and pharmacists.
“It allowed for a collaborative partnership across
multiple healthcare settings (inpatient, ED, and even
PICU) while bringing in the expertise of various
healthcare disciplines to standardize processes including
albuterol titration via pathway, albuterol nebulizer
dosing, and steroid administration.” (Site 14)
“We wanted to make sure that we were providing the
best possible care for our asthma patients through
collaboration with ED, inpatient, pharmacy,
respiratory and nurses.” (Site 37)
Barriers to implementation
Theme 1: Implementation leaders described difficulties
in modifying electronic health records as a common
barrier to implementation.
“We initiated the process, but need to obtain
approval and buy-in from 5 affiliated hospitals in
order to update the inpatient pathway and change the
order set and respiratory score in the EHR.” (Site 83)
“Other [EHR] builds have taken priority thus we do
not have a specific order set in place.” (Site 52)
Theme 2: Implementation leaders also reported dif-
ficulty obtaining consensus on practice changes as a
barrier to implementation. This especially applied to
changing the scope of practice of nurses and/or
respiratory therapists in autonomously titrating albu-
terol per pathway recommendations.
“[There were] many institutional barriers to
implementing new processes that involve nurses
performing additional tasks or making ‘clinical
decisions’ such as spacing albuterol, which were viewed
as outside the scope of practice by some.” (Site 66)
“MDs were not comfortable that the RNs were
scoring patients correctly, and therefore
uncomfortable with them weaning patients.” (Site 12)
Reach
Among the 5557 patients cared for after pathway
implementation, 3502 (63%) had an electronic path-
way order placed (Table 4). Rates of placement of
pathway orders ranged widely across hospitals, with a
median of 73% and IQR of 20-97%. Pathway order
placement did not differ significantly by patient age,
sex, or prior inhaled corticosteroid use. Patients with
public insurance were more likely to have a pathway
order placed than children with private insurance.
Discussion
Several studies have demonstrated that pathways are
effective in improving quality of care and health out-
comes for children hospitalized with asthma (3–9,12).
However, none, to our knowledge, have detailed the
pathway implementation process across a large, diverse
group of hospital settings. We found that pathway
implementation was feasible across diverse hospital set-
tings, with 80% adopting/completing the collaborative
and successfully completing pathway implementation in
a median of 5months. Implementation leaders found
pathway implementation valuable, and the national
learning collaborative provided critical supports for
improving pediatric asthma care, including educational
materials and videoconferences. Implementation leaders
found that modifying EHRs posed a significant barrier
to improvement efforts, and this may have limited the
Table 4. Characteristics of children for whom pathways were ordered versus not ordered.
Patient Characteristics Pathway Order (n¼ 3502) No Pathway Order (n¼ 2055) p-value
Male (n, %) 2120 (60.5%) 1239 (60.3%) 0.27
Age in years (median, IQR) 5 (3, 9) 5 (3, 9) 0.59
Prior Inhaled Corticosteroid Use (n, %) 1760 (50.3%) 998 (48.6%) 0.97
Insurance (n, %) 0.03
Private 2102 (60%) 1429 (69.5%)
Public 1048 (29.9%) 532 (25.9%)
Tri-care 47 (1.1%) 15 (1.1%)
Other, Self-pay, or Unknown 190 (5.4%) 62 (3.0%)
Insurance was used as a proxy for socioeconomic status. Public insurance is provided for children whose families earn less than 133%
of the federal poverty level (20). Tri-care insurance is provided for children of families with members serving in the U.S. military.
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reach of pathways to children hospitalized with asthma.
Policymakers, clinicians, and hospital leaders seeking to
improve care for hospitalized children can use these
findings to guide future pathway implementation efforts.
The 20% drop out rate we experienced is similar to
prior studies of quality collaboratives focused on
implementing pediatric evidence-based guidelines
(21,22). But our findings illuminate the common bar-
riers that were associated with discontinuing participa-
tion. Lack of support from hospital leadership/
administrators was commonly reported. This barrier
may be heightened in community hospital settings,
which predominantly care for and prioritize resources
for adults (23). Early engagement between implemen-
tation leaders and hospital administrators to discuss
the goals and potential benefits of pathway implemen-
tation may help overcome this barrier (10).
Physician implementation leaders reported difficulties
in modifying the EHR, and only 57% of hospitals were
able to integrate pathway content into the EHR by the
end of the 15-month collaborative. This likely played a
role in limiting the reach of electronic pathway orders
to only 63% of children hospitalized with asthma.
Difficulties in modifying EHRs have been reported as a
barrier in prior qualitative studies of asthma pathway
implementation (10), and have been associated with
poor performance prior studies of pediatric learning col-
laboratives (24). EHRs can be leveraged to support path-
way implementation in a number of ways, including
providing clinical decision support for providers in the
form of order sets, linking providers to more detailed
evidence-based guidelines, enabling communication
between providers, and automating data collection on
the pathway implementation process (e.g.use of the
pathway, clinical outcomes) (10). Central development
of pediatric asthma order sets by commonly used EHR
manufactures or streamlining of workflows needed to
modify EHRs may help overcome this barrier. However,
more research is needed to identify efficient ways to add
functionality to EHRs and to understand how to opti-
mize EHR modifications to improve quality of care.
Physician implementation leaders were satisfied with
and valued pathway implementation. The benefit they
most frequently reported was improvements in quality
of care, including improvements in patient-centered out-
comes (e.g.recovery time/length of hospital stay).
Leaders also reported that improvements in care
extended to children with other conditions than the
condition of focus, asthma. This was because pathway
content and educational materials (e.g.smoking cessation
resource referral, respiratory scoring) sometimes applied
to the care of children with other respiratory illnesses.
Another benefit of pathway implementation was
enhanced interdisciplinary collaboration across providers
and units of the hospital (e.g.emergency department,
intensive care unit). These findings indicate that the
benefits of inpatient pediatric asthma pathway imple-
mentation may extend far beyond the population of
interest, potentially to all children cared for across many
settings within a hospital.
Physician implementation leaders also highlighted
the critical supports provided by the national learning
collaborative. External development of the pathway
toolkit and educational materials saved local implemen-
tation leaders’ time. Leaders also reported that these
resources were powerful in motivating practice change,
because they were vetted by a reputable national organ-
ization (AAP). The collaborative also provided connec-
tions to peers at other hospitals that were engaged in
pathway implementation. Implementation leaders
reported that these connections facilitated sharing of
implementation learnings. Thus, learning collaboratives
may provide crucial supports for disseminating and
implementing pathways and improving quality of care
(21,22,24). Indeed, the Value in Inpatient Pediatrics
Network has seen growing demand for its national
learning collaboratives, with a rise in participation from
17 hospitals to over 100 hospitals between 2008 and
2018 (13).
In this study, we applied an established implemen-
tation science framework (16) and used mixed meth-
ods to provide a global and detailed evaluation of the
asthma pathway implementation process. We used a
diverse, national sample of hospitals. However, this
study has limitations. First, most data were gathered
via self-report from physician implementation leaders
only. Surveying other types of clinicians or patients/
family members may have yielded different perspec-
tives and results. To our knowledge, patients and fam-
ily members have not yet been included in pediatric
asthma pathway research, thus, represent an import-
ant future area of study. However, these physician
implementation leaders were the most knowledgeable
regarding the pathway implementation process we
sought to evaluate. In addition, some survey data was
provided retrospectively and may be affected by recall
bias. We were only able to verify implementation data
at 4 hospitals, and this sample may not be generaliz-
able to all participating sites. However, the subset of
sites that were visited showed high validity of the sur-
vey responses (19 of 20 responses verified as correct).
We defined reach as placement of a pathway/protocol
order in a patient’s chart, but this could not capture
use of a paper pathway/protocol in the patient’s care
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or use of other core pathway components. While this
may underestimate the true “reach” of the interven-
tion, it was the best marker of reach available via
chart review and feasible to collect during this study.
Lastly, our analysis was not able to determine which
implementation practices, such as EHR integration,
are most effective in improving quality of care.
Conclusions
Pathway implementation is both feasible and effective
in improving care for children hospitalized with
asthma across diverse hospital settings and should be
prioritized by policymakers, hospital leaders, and
clinicians. Important areas of future research include
understanding the perspectives of patients and family
members, identifying ways to improve the ease and
effectiveness of EHR modifications, and determining
how to ensure sustained improvements in care.
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